5 days ago
In an interview with a rodent Stuart Ashman of Skinbiotherapeutics (SBTX) branded me a “prolific liar” without actually evidencing one single lie. Anyhow on the question of prolific liars…
18 days ago
As discussed in bearcast earlier, shares in Skinbiotherapeutics (SBTX) may or may not be cheap or expensive. What I neglected to say is that some are arguing that the continued buying by Mark Dixon, he now owns 16.2%, shows that they are cheap: he would not buy so many shares if he did not know something. Hmmmm.
29 days ago
I discuss how Stuart Ashman is deluding himself yet again at Skinbiotherapeutics (SBTX) and a sell off and general slapping for gold and silver.
34 days ago
As Stuart Ashman snuggled back underneath his Angel of the North duvet in his palatial mock Georgian mansion he tried hard to dismiss his two meetings with the ghostly figure and his reminder of past events in London and of Christmas this year in Yahya Sinwar Close Coventry. But try as he might, sleep eluded him. He tossed and he turned and out of the window he started to see the first signs of light in the sky. Was that Christmas dawn or…
35 days ago
As Stuart Ashman snuggled back underneath his Angel of the North duvet in his palatial mock Georgian mansion he tried hard to dismiss his earlier meeting with the ghostly figure and his reminder of past events. But try as he might, sleep eluded him.
36 days ago
‘twas the night before Christmas and Newcastle’s second greatest thinker after Anthony McPartlin gazed out of the windows of his mock Georgian farmhouse onto snow covered fields. In the far distance he could see the headlights of stolen cars as the poor people hurried back from the foodbanks ahead of the big day.
39 days ago
The overpaid Geordie poltroon and prolific teller of his truths who, pro tem, acts as CEO of Skinbiotherapeutics (SBTX) says that he cannot give us any detail about sales to Croda (CRDA) because of NDAs so here is an easy question he can answer….
41 days ago
Skinbiotherapeutics (SBTX) has today confirmed that it is still on track to meet broker forecasts which it confirmed it was on track to meet with results on December 5. Wow: 13 days without a profits warning, give Stuart Ashman a bonus. What a prick. But then it turns to the AGM where it says it has posted a Q&A in response to some shareholder questions. It dissembles.
41 days ago
Bearded Geordie poltroon Stuart Ashman says without citing one actual example that I am a “prolific liar.” The overpaid and under-delivering CEO of Skinbiotherapeutics (SBTX) thinks that he always tells the truth. Let’s rewind to June 16th when shareholders were 10% diluted in a £4.2 million placing.
43 days ago
You really could not make thus up. A week ago Skinbiotherapeutics (SBTX) sent out a notice of its AGM on 29 December at 9 AM in a grim suburb of Newcastle with minimal public transport links. And folks started voting on AGM Resolutions including the re-election of the whole board, as per QCA guidance. But clearly folks were voting the wrong way.
47 days ago
Unable to sleep last night I checked out the Superdrug website and to have a look at the Skinbiotherapeutics (SBTX) acne and psoriasis products.
Acne sure is a crowded field, Superdrug sells 376 products including the one from Skins.
47 days ago
The audio clip below is from an interview conducted by a small furry rodent and Stuart Ashman the CEO at Skinbiotherapeutics (SBTX). Natch the defamatory statement is not corrected or challenged by the rodent.
48 days ago
I sense that there will be more folks than Stuart Ashman was expecting who are planning to make the trek up to a post industrial suburb of Newcastle on December 29 to attend the Skinbiotherapeutics (SBTX) AGM. I should warn you that the forecast is of a temperature that feels like 2 degrees with a 99% chance of rain. It’s grim up north. I have at least one spy attending who will report back on what happens. It is Ashman and clueless chairman Martin Hunt who deserve the toughest grilling but the NEDS will also be attending.
48 days ago
That is the remarkable claim made by Stuart Ashman who claims to spend half his working life dealing with investor complaints. I assume he spends the other doing things which give folks reason to complain. After discussing that I look at Premier African Minerals (PREM) and Procook (PROC)
49 days ago
Stuart Ashman, the incompetent in charge at Skinbiotherapeutics (SBTX) recorded a podcast with the sycophantic poltroon Lemming yesterday in which he made statements which surely AIM Regulation must be all over. This is just not the way a CEO should conduct himself, even if the audience is only 23, as the maths just does not stack up.
50 days ago
I have had enough of scumbags on the London small cap scene for today and especially of Stuart Ashman of Skinbiotherapeutics (SBTX). With two new revelations I explain why I am out.
51 days ago
I have now written to both regulators demanding a full enquiry into Stuart Ashman and Skin biotherapeutics (SBTX) as , at the very least , they have broken AIM Rule 10 at worse they have done a placing at a false price because of non disclosure to the wider market of adverse trading performance. In the wake of December 5 prelims there now needs to be a full formal enquiry
51 days ago
Skinbiotherapeutics (SBTX) insists that it follows the QCA code of corporate governance. But like so much else it says that is simply not true. Now I add to Stuart Ashman’s growing rap sheet a charge of cowardice.
51 days ago
On 22 March 2024 as he unveiled piss poor interims for Skinbiotherapeutics (SBTX) Stuart Ashman insisted in an RNS that, in the manner of Call Me Dave Cameron we were all in it together and to show solidarity with we mug shareholders he was taking a pay cut of 20% backdated to January 1. His hapless, then FD, Manprick made a similar gesture.
52 days ago
Laughably Stuart Ashman of Skinbiotherpeutics (SBTX) yesterday praised his bean counter Emily Bertram for her good work and said she’d be promoted for that good work (ching ching for young Emily) in January. This came on a day when June 2025 results finally emerged and contain two material breaches of IFRS. And Emily is being praised and rewarded for her blunders? I have written to my good pals at the FRC…
53 days ago
No doubt the colony of small furry mammals living where the sun don’t shine will see this video posted below as a triumph but the post results Proactive video from Stuart Ashman at Skinbiotherapeutics (SBTX) shows him as an A grade prick who shareholders should dump at the AGM. He starts by saying how pleased he was to have met forecasts for the year to June 30th 2025. How can he say that with a straight face?
54 days ago
I do not know what the FCA would find about events in June but it needs to look. Meanwhile I go through all the reasons why, if he had any honour, the Skinbiotherapeutics (SBTX) boss would be starting to work out his notice today.
55 days ago
Our dear leader Sir Keir Starmer is postponing a raft of elections due next year showing a total contempt for democracy and, in effect, blocking the ascent of the saintly Councillor Bick up the Greasy Pole. But TTK appears not to be the only anti democrat in town. I had suggested that comrade Lemming Investor lived in Stuart Ashman’s posterior, now it seems as if the Skinbiotherapeutics (SBTX) CEO is housing a whole family of furry rodents.
56 days ago
Tomorrow sees the AGM of the insolvent fraud Supply@ME Capital (SYME) and unlike Stuart Ashman’s Skinbiotherapeutics (SBTX) it does not treat its shareholders, though they are by definition complete morons, with obvious contempt.
85 days ago
Our in house bien pensant PL appears to have stumbled on forecasts from credible tier 1 brokers for how much revenue Croda (CRDA) will make from sales of the Skinbiotherapeutics (SBTX) product Zenakine. The source of this is, PL says, AI so it may be hogwash but it, perhaps, raises two critical points.
92 days ago
Does anything still work in the UK? I detail my latest encounter with the Shipmans and the NHS. Then a dim Tory and personal vindication at Petrofac (PFC). I look at Alien Metals (UFO) and predict a Turner Pope deeply discounted placing soon and finally I put forward a thesis about Skinbiotherapeutics (SBTX). If I am right should Stuart Ashman fall on his sword?
110 days ago
Ed from Islington and others are unsettled by Companies House Filings from Skinbiotherapeutics (SBTX). Once again, in terms of transparency and governance Stuart Ashman seems determined to score another own goal.
127 days ago
I am not saying that Stuart Ashman has goofed operationally. But in terms of being transparent with investors he really is clueless and I say that in a spirit of Christian compassion.
140 days ago
Very ostentatiously the bearded Poltroon, Stuart Ashman of Skinbiotherapeutics (SBTX) and his, now thankfully departed, CFO Manprick took a 20% pay cut in early 2024 backdated to January 1 of that year. They did so as targets had been missed and more shares had needed to be issued. As Call Me Dave used to, mendaciously, comment “We are all in it together.”
140 days ago
The pretext for the June 16 placing by Skinbiotherapeutics (SBTX) conducted before the company ‘fessed that it was going to miss June 30 revenue forecasts by a country mile, was that cash was needed for a new product launch with Superdrug.
160 days ago
A helpful reader supplies a video of a man that certain commentators, habitually resident a long way up a Tyneside rectum, say that I really should respect and not refer to as the bearded, troughing, useless Geordie poltroon. That is to say Skinbiotherapeutics (SBTX) CEO Stuart Ashman. In it he discusses the forecasts published on July 7 by Singer analyst Karl “Kevin” Keegan.
164 days ago
The emails going out to institutions and private investors alike urge folks to vote CEO Stuart Ashman off the board of Skinbiotherapeutics (SBTX) at its AGM which it likes to hold between Christmas and New Year in Tyneside to ensure minimal attendance. I am happy to say that I shall vote my shares that way. The letter reads:
167 days ago
I just cannot see how Skinbiotherapeutics (SBTX) did not lead investors up the garden path, by omission not act, ahead of the June 16 2025 placing raising £4.2 million at 17p. Heads really should roll and if Nomad Singer is too weak to act against disgraced CEO Stuart Ashman and the company I have written to both the FCA and the Oxymorons at AIM Regulation asking for an immediate enquiry.
191 days ago
I am not blaming my pal the Lemming before the sensitive little fellow complains. He has done nothing wrong and indeed everything right in reporting what the bearded and grossly overpaid Geordie poltroon Stuart Ashman at Skinbiotherapeutics (SBTX) has said to him. But surely Ashman is breaking AIM Rule 10.
194 days ago
I start with Skinbotherapeutics (SBTX) and more nonsense from Stuart Ashman c/o the Lemming. Then Zenith Energy (ZEN). Argentex (AGFX) and the great and the good getting off lightly, Technology Minerals (TM1), AFC Energy (AFC), Genflow Biosciences (GENF) and a call to snap up one of the last 12 seats for ShareStock HERE UPDATE I refer to Zephyr in recording I mean Zenith! I am going senile.
203 days ago
The Singer’s initiation note on its corporate client Skinbotherapeutics(SBTX) is a curious piece of fish. For staters Singer’s makes it clear that it will not, under any circumstances, be made available to private investors it is for II’s and City HNWIs only. This is pointless.
205 days ago
This will count as an extra 11th article for the reader who does not want to read about Optibiotix (OPTI) or Skinbiotheraputics (SBTX)again.
212 days ago
I start off with Warwick School paedophile teachers, the failure of the CPS, how Warwick covered it up so causing boys elsewhere to be abused and one nonce in particular Alan Wilkins. For it was he who introduced me to the idea of a balloon debate. The main point of this bearcast is discussing today's news from Skinbiotherapeutics (SBTX) and Optibiotix (OPTI)
212 days ago
The bearded Geordie poltroon wonders why shares in Skinbiotherapeutics (SBTX)( languish at just over 16p. One major reason is that he keeps on being shown to be a liar and folks do not rush out to buy shares in companies that are run by liars. I have already shown him telling porkies about not needing a placing only to do a placing HERE. Now today we have a statement on Croda (CRDA).
225 days ago
Today Skinbiotherapeutics (SBTX) has announced that Superdrug is to sell its acne and psoriasis products. That is the good news. But to fund the rollout it has diluted us all by another 10% with a placing. On 16 April CEO Stuart Ashman recorded an Investor Meet video. Here are two clips. Please can anyone explain why he is not now exposed as a 100% lying scumbag?
230 days ago
231 days ago
251 days ago
It is no secret that I am not the biggest fan of the Skinbiotherapeutics (SBTX) boss but I explain why I feel rather sorry for him today and what he should do.to get tiresome mug punters off his case.
279 days ago
Folks like the Lemming thought that Skinbiotherapeutics (SBTX) FD Manprick Randhawa was the bees knees and were jolly cross with me for rebranding him for his patent incompetence. In my view he was useless, unable to communicate with serious investors or to stop Stuart Ashman abusing the word accretive and, at least, partially responsible for the cack handed and dilutive financing of two acquisitions. He was unable to control costs. Well, today, he has gone to pursue other business interests. Great news.. It has prompted me to buy more shares, increasing my holding by 25%.
286 days ago
I am not normally one to praise Stuart Ashman the CEO and Manprick the grossly overpaid CFO at Skinbiotherapeutics (SBTX) but yesterday’s investor meet presentation and Q&A was a very good showing by them both, especially Ashman. There I have said it. My key takeaways are:
294 days ago
295 days ago
310 days ago
336 days ago
408 days ago
The only Geordie I wish to see on video is called Cheryl. Sadly, she is not the boss at Skinbiotherapeutics (SBTX) as she’d be far less likely to arrange financings with proven fraudsters than Stuart Ashman. Anyhow Ashman and his grossly overpaid FD Manprick have recorded the video below. Notwithstanding this company’s management, I continue to regard the shares, at 16.75p, as very cheap and perfectly capable of trebling or indeed being a six bagger within 18 months. Enjoy. Or should that be, endure.
414 days ago
Skinbiotherapeutics (SBTX) is very simple. If you believe that Croda could deliver £25 million GP or anywhere close to that as CEO Stuart Ashman has intimated the shares are stupendously cheap at 17.75p. Ashman needs to do nothing apart from deliver other corporate deals and more GP from his existing IP and no more shares need be issued. Hell’s teeth why issue shares now or indeed at twice or three times the price given that on Ashman’s Croda numbers the shares could easily be 100p or even 200p! But Ashman is a git.
572 days ago
My real beef with Stuart Ashman, the CEO of Skinbiotherapeutics (SBTX) is not his grotesque pay package and the fact that he snaffled a pay rise last year when his company headed backwards operationally. Nor is it that he tells overt porkies with his “Rules are rules” claims. My real gripe is, as explained in bearcast today, how poor decisions made by him have cost we loyal shareholders badly. Losing 2/3 of the share price in less than three months is worse than careless. But back to the lying.
608 days ago
The bearded poltroon in charge of Skinbiotherapeutics (SBTX), where I remain a loyal shareholder, says that “rules are rules” and that AIM Regulation has insisted that he cannot do a video interview with me inside a paywall. That is a lie and I am now in dialogue with the Oxymorons who so far, as you can see, are evasive. For what it is worth, hapless moron Giles Balleny at Nomad Cavendish has already been shown to be lying by events elsewhere.
608 days ago
The underpants obsession is explained HERE for those not up to date on Mincemeat matters. Then it is onto gold juniors and majors the gold price, Verditek (VDTK), Supply@ME Capital (FRAUD) and a letter to AIM Regulation to call out Stuart Ashman as a liar. Rules are rules.
610 days ago
It was an hour of my time which I may look back on my deathbed and consider an hour wasted. I should say that, on balance, there was enough offered by Ashman to make me content to hold shares in Skinbiotherapeutics (SBTX) but there were also worrying matters not least the CEO telling a blatant lie.
621 days ago
In today’s podcast I discuss retirement postponed thanks to Joshua and to Stuart Ashman. I chat about Optibiotix (OPTI), en passant, but in depth about Skinbiotherapeutics (SBTX) with apologies to those who have lost money. Here is what should happen next.
652 days ago
Yesterday I exposed how Cavendish, the Nomad, to Skinbiotherapeutics (SBTX) had banned its boss Stuart Ashman from doing interviews with me as the videos would be behind a paywall. It gets worse, as a kind reader points out.
654 days ago
This is Orwellian and shows that Giles Balleny of Nomad Cavendish (formerly Finncrap & Cenkos pre merger) is either thick as pig shit or morally bankrupt or both. Given he works for Cavendish I reckon it is both. He has ordered Stuart Ashman of Skinbiotherapeutics (SBTX) to record no more videos with me.
663 days ago
In today’s bearcast I start with happy events in London last night to cheer both myself and the Euroloon Jonathan Price. Then it is on to Verditek (VDTK), Canadian Overseas (COPL), Regtech Open (FRAUD) and Supply@ME Capital (FRAUD) all four of which owe us statements. Then Kefi Gold & Copper (KEFI) and Skinbiotherapeutics (SBTX).
688 days ago
I have emailed Stuart Ashman, the boss of Skinbiotherapeutics (SBTX) this morning with, what I believe to be, a helpful suggestion.
698 days ago
I start with it being the first day of Advent and a moan about folks starting Christmas far too early. Then onto Skinbiotherapeutics (SBTX), why I am not selling and a suggestion for Stuart Ashman, a serious one, on how he can regain investor trust at a stroke. Then it is Tintra (TNT), Ceres Power (CWR), free speech on this website, Totally (TLY), Vast Resources (VAST) and Rua Life Sciences (RUA),the sponsor of today’s ouzo moment.
698 days ago
I still think Skinbiotherapeutics (SBTX) shares are cheap after results which were snuck out after hours yesterday. However, I want to flag up that for a company with sales lower than that of my local CO-OP and which spunked c£3 million in each of the last two years, the boardroom pay is obscene and just cannot be justified. The worst offender is the Sus barbatus himself, CEO Stuart Ashman.
702 days ago
I guess that while Stuart Ashman might have taken me off his Christmas card list after my recent bearcast on Skinbiotherapeutics (SBTX), Steve O’Hara at Optibiotix (OPTI) seems to agree with my analysis. We have swapped emails this morning after the publication of a TR1.
707 days ago
SkinBioTherapeutics (SBTX) has announced a placing and “retail offer” at 19p per share to raise, respectively, a minimum of £3 million and up to £0.25 million, with CEO Stuart Ashman stating this is needed “to help with the current commercialisation and development strategy of AxisBiotix in skin health, with our latest venture beginning in acne, as well as providing a stronger financial base to support our strategic partnering discussions around three of our other business pillars. The funding will also support us with working capital and strengthen our balance sheet”. Tom Winnifrith has applied for shares in the offer and we suggest you do too BUT Ashman is talking bollocks and we will be slashing our target price from 150p.
709 days ago
In this bonus Bearcast, I explain why I am cutting my target price materially for Skinbiotherapeutics (SBTX) but still see this as a potential five bagger. I am furious with Stuart Ashman who is greedy and has not delivered. And I think the company’s broker, Cavendish, has a lot of questions to answer. I warn you that Matthew’s Dog and Catriona will love this podcast.
713 days ago
I have been involved with the stockmarket for 33 years. I have done almost every job going: analyst, CEO, fund manager – crap one – even, don’t laugh, compliance officer so I get really fucked off when folks lecture me about what the rules are, especially when they clearly don’t know them themselves. I really do not like being patronized and that brings me to Stuart Ashman and Skinbiotherapeutics (SBTX) where I am, of course, a loyal shareholder.
869 days ago
Apologies for the introduction, long covid. In today’s podcast I discuss why what Gary or I say about a given stock does not matter, in the long run what matters is cash generation or lack of it. I discuss what Stuart Ashman and Steve O’Hara said about Gary’s bear piece yesterday. I discuss house prices. And I flag up that there are now just 12 tickets left for Sharestock so if you want to come book now HERE
902 days ago
I am back with these bonus video shows. I am still re-adjusting myself to Zoom so if my face looks a bit funny in part 4 there is a reason. In this show I interview Stuart Ashman of Skinbiotherapeutics (SBTX), dissect that interview myself and then ask if Oacdo (OCDO) really is the Number 1 FTSE 100 short or one for the bears to dodge. I hope you enjoy the show.
946 days ago
I am told by at least one reader that a 1 million shares sale in Skinbiotherapeutics (SBTX) MUST be Optibiotix (OPTI). The bulletin boards are full of ill-informed speculation. I am in a good mood today because West Ham are Massive so I shall not label such folks morons. Okay I will. They are morons. I have swapped emails with both Steve O’Hara of Optibiotix and Stuart Ashman of Skins.
1117 days ago
I do not always agree with Mr Lemming Investor but for what it is worth we are both still bulls of Skinbiotherapeutics (SBTX). He posted this Q&A with Stuart Ashman the other day and it is worth a read. Over to the Lemming:
1118 days ago
SkinBioTherapeutics (SBTX) has announced no-one watching o’clock (4:30pm) results for its year ended 30th June 2022, with CEO Stuart Ashman stating “this financial year has been a mixed one for the group”. With the results coming with a potentially £3.5 million equity raise (albeit including an up to £1 million “retail offer”) at 16p per share, we’ve got some other words for it but where does this all leave the company now?
1229 days ago
Let us be clear. When I said that Staurt Ashman said that month on month sales doubled in both July and August I said so because the bearded loon said so in an email to me. For him to backtrack as he does in this interview and suggest that “Mr Angry” is a bit confused, therefore makes me a bit more er….angry. If you have an hour of your life to spare, enjoy.
1243 days ago
In today’s bearcast I look in detail at Cake Box (CBOX), nanosynth (NNN) and Skinbiotherapeutics (SBTX).
1332 days ago
I discuss both these corporates, and remind the 94% of you yet to support Rogue Bloggers for Woodlarks: please do so, HERE. Then, I discuss Stuart Ashman of Skinbiotherapitics (SBTX), who has made me look like a complete git (again), as he withdraws from ShareStock. But, I will announce another BIG-name speaker tomorrow, and will replace Stuart. So, make sure you book your tickets, HERE. Then, I look at Cellular Goods (CBX) and Guild ESports (GILD), the David Beckham dogs.
1399 days ago
I start with Mello Events, which last night exposed itself as a PR promoter, failing to allow any questions about the elephant in the room: musicMagpie(MMAG). Then to Optibiotix (OPTI) and Skinbiotherapeutics (SBTX), after today’s news from the latter. I have spoken to both Steve O’Hara and Stuart Ashman. As Les points out in the comments section, the silver lining for you is the postponement of my retirement – but not for long. The market has over-reacted: long-term, these two companies will subsidise the goat farm, as I explain in detail.
1437 days ago
As you know I am reviewing my pension as discussed HERE. As such I am chatting to various CEOs who I have backed and yesterday evening I had a long chat with Stuart Ashman of Skinbiotherapeutics (SBTX). He is not a bluffing promoter but, I believe, a sober and grounded chap. I came away from the call just incredibly excited. I explain why the share price is where it is but also why this could within a couple of years be a 10 bagger but it could equally be a 20 bagger. Certainly any free cash within my SIPP will, even at twice today’s price be going into this stock. And if I am right there is a clear implication for Optibiotix (OPTI) so I am not selling any shares in it either. Footnote/correction. There are not 2 million psoriasis sufferers worldwide as per podcast but 120 million. I can’t say that weakens the case!
1505 days ago
In today’s podcast I discuss why I worry that my wife may have become a real housewife of posh Cheshire, not the part where they play rugby league. Then I look at ADM Energy (ADME) and that RNS reach issue again, tell you about a psychic moron who owns shares in Supply@ME Capital (SYME) and then I discuss, at length, Skinbiotherapeutics (SBTX) after a chat with CEO Stuart Ashman today and on the back of that I have bought more shares in the company.
1533 days ago
As predicted HERE the print going through late on Friday was Optibiotix (OPTI) dumping £2 million worth of Skinbiotherapeutics (SBTX) at 55p. I told you that this would happpen weeks ago producing more bluster and fake denials from all involved. Fuckers! The release this morning insults the intelligence of we loyal shareholders in both companies yet again. Stuart, Steve, posh PR bird Melanie Toyne-Sewell and the scumbags at Cenkos do you think we are idiots? You treat us as if we are.
1837 days ago
And now from Wales, by just 30 yards, it is my new weekly video show. This costs 99p per episode, and you can either listen to, or watch, some sparky interviews with Staurt Ashman of Skinbiotherapeutics (SBTX) where I am 130% up in seven months but think the shares could 20 bag from here and bear raider Lucian Miers on macro economics his cooling feelings on cold and warming feelings on bitcoin and his big longs and shorts. Then there are a few thoughts on companies you must NOT own, including the latest nonsense from the scallywags at Powerhouse Energy (PHE).You can access the show HERE
1927 days ago
Skinbiotherapeutics (SBTX) boss Stuart Ashman until today held zero shares in the company. And he told us all that it had enough cash to last it until the end of next year at least. And so now there is a £4 million placing and £500,000 open offer at 16p. Mr Ashman can you see why I might be annoyed?
2044 days ago
And now from Wales, by just 30 yards, it is my new, I hope, weekly show. This costs 99p per episode, and you can either listen or watch very sparky interviews with our in-house gold guru Nigel Somerville on why you must be in gold and on the stocks or ETFs to own to maximise your bull market gains and with Union Jack Oil (UJO) boss David Bramhill, the most underpaid oil CEO on AIM. I also serve up a red flag-spotting session with reference to Diversified Gas & Oil (DGOC). You can access the show HERE
